Steffen Boettcher

26PUBLICATIONS
152CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesMolecular targetsGene and molecular therapyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Oct 01, 2026
Functional Classification of Monoallelic TP53 Mutations Refines Prognostic Stratification in Myelodysplastic Neoplasms.

|Sep 25, 2026
SLIT2 modulates leukaemic cell proliferation and stromal support in acute myeloid leukaemia models.

|Aug 17, 2026
Dual MYC and GSPT1 Protein Degrader for MYC-Driven Hematologic Malignancies.

|Jul 13, 2026
The Novel Hypomethylating Agent NTX-301 Reprograms Epigenetic and Hippo Signaling Pathways and Exhibits Preclinical Activity in Venetoclax-Resistant and TP53-Mutant AML.

|Jan 06, 2026
Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.

Roman R Schimmer, Nancy Klemm, Jonas Fullin

|Dec 17, 2025
The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis.

Jonas Fullin, Ebru Topçu, Karolina A Zielińska

Pageof 5

Frequent Collaborators

8 joint publications

Markus G Manz

8 joint publications

Benjamin L Ebert

7 joint publications

Lauren B Ostermann

7 joint publications

Michael Andreeff